This suggests that – although the predisposition to hyperinsulinism applies to Kabuki syndrome, in general – the defect of KDM6A may more specifically impact β-cell function compared to a defect of KMT2D (60). The gene discussed is KDM6A; the disease is Kabuki syndrome.